IL52942A - Pharmaceutical compositions containing l or dl phenyl glycines - Google Patents

Pharmaceutical compositions containing l or dl phenyl glycines

Info

Publication number
IL52942A
IL52942A IL52942A IL5294277A IL52942A IL 52942 A IL52942 A IL 52942A IL 52942 A IL52942 A IL 52942A IL 5294277 A IL5294277 A IL 5294277A IL 52942 A IL52942 A IL 52942A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
phenyl glycines
glycines
phenyl
Prior art date
Application number
IL52942A
Other languages
English (en)
Other versions
IL52942A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL52942A0 publication Critical patent/IL52942A0/xx
Publication of IL52942A publication Critical patent/IL52942A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL52942A 1976-09-28 1977-09-16 Pharmaceutical compositions containing l or dl phenyl glycines IL52942A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB40306/76A GB1547206A (en) 1976-09-28 1976-09-28 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IL52942A0 IL52942A0 (en) 1977-11-30
IL52942A true IL52942A (en) 1980-10-26

Family

ID=10414240

Family Applications (1)

Application Number Title Priority Date Filing Date
IL52942A IL52942A (en) 1976-09-28 1977-09-16 Pharmaceutical compositions containing l or dl phenyl glycines

Country Status (18)

Country Link
US (1) US4148920A (xx)
JP (1) JPS5341432A (xx)
AU (1) AU502041B2 (xx)
BE (1) BE859151A (xx)
CA (1) CA1082600A (xx)
DE (1) DE2743704C2 (xx)
FR (1) FR2365340A1 (xx)
GB (1) GB1547206A (xx)
GR (1) GR69785B (xx)
HK (1) HK69380A (xx)
IE (1) IE46491B1 (xx)
IL (1) IL52942A (xx)
LU (1) LU78177A1 (xx)
NL (1) NL7710518A (xx)
NZ (1) NZ185173A (xx)
PH (1) PH14867A (xx)
PT (1) PT67080B (xx)
ZA (1) ZA775433B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH14064A (en) * 1977-05-06 1981-01-26 Pfizer Phenylgycine derivatives,pharmaceutical compositions and method of use
PH14681A (en) * 1977-11-30 1981-11-10 Pfizer Phenylglycinamides useful in the treatment of ischaemic heart disease
EP0009326A3 (en) * 1978-08-30 1980-04-16 Pfizer Limited Pyrrolyl keto and amino acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
EP0026593A1 (en) * 1979-09-15 1981-04-08 Pfizer Limited Bicyclic keto- and amino- acids, esters and amides and pharmaceutical compositions thereof
RU2137472C1 (ru) * 1998-10-12 1999-09-20 Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН Лекарственный препарат "гистохром" для лечения острого инфаркта миокарда и ишемической болезни сердца
CN102165950B (zh) * 2011-03-10 2014-02-26 浙江大学 苯基甘氨酸衍生物对大肠杆菌有抑菌和杀菌活性

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795874A (fr) * 1972-02-25 1973-08-23 Glaxo Lab Ltd Procede de preparation d'esters optiquement actifs d'alpha-amino-acides
JPS5132541A (en) * 1974-09-12 1976-03-19 Fujisawa Pharmaceutical Co Dll22 * 44 hidorokishifueniru * gurishinnokogakubunkatsuho
US3976782A (en) * 1975-03-25 1976-08-24 Merck & Co., Inc. 3-(2,5-Dihydroxyphenyl)-alanine as a cardiac stimulant

Also Published As

Publication number Publication date
JPS5341432A (en) 1978-04-14
HK69380A (en) 1980-12-19
AU2883977A (en) 1979-03-22
GB1547206A (en) 1979-06-06
IE46491B1 (en) 1983-06-29
IE771967L (en) 1978-03-28
GR69785B (xx) 1982-07-07
US4148920A (en) 1979-04-10
FR2365340A1 (fr) 1978-04-21
IL52942A0 (en) 1977-11-30
AU502041B2 (en) 1979-07-12
NZ185173A (en) 1984-05-31
CA1082600A (en) 1980-07-29
DE2743704C2 (de) 1983-10-27
LU78177A1 (fr) 1979-05-25
PT67080A (en) 1977-10-01
PH14867A (en) 1982-01-08
PT67080B (en) 1979-02-22
DE2743704A1 (de) 1978-03-30
FR2365340B1 (xx) 1981-12-04
NL7710518A (nl) 1978-03-30
ZA775433B (en) 1978-08-30
BE859151A (fr) 1978-01-16

Similar Documents

Publication Publication Date Title
ZA771091B (en) Pharmaceutical compositions
ZA774920B (en) Pharmaceutical compositions
PT66622B (en) Pharmaceutical compositions
ZA771003B (en) Pharmaceutical compositions containing pyrethrinoides
JPS52113976A (en) Pharmaceutical composition
AU3111677A (en) Pharmaceutical compositions
NZ184539A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions
AU3152677A (en) Pharmaceutical composition
NZ186147A (en) Sterolin pharmaceutical compositions
AU2609277A (en) Pharmaceutical compositions
ZA805666B (en) Pharmaceutical compositions containing paracetamol
AU2649977A (en) Pharmaceutical composition
IL52942A (en) Pharmaceutical compositions containing l or dl phenyl glycines
NZ192021A (en) Pharmaceutical compositions containing aryltrifluoroethanols
IL62517A (en) Pharmaceutical compositions comprising cisplatin
IL52103A0 (en) Pharmaceutical compositions containing naphthopyrane derivvatives
DE3064666D1 (en) Pharmaceutical compositions containing paracetamol
NZ185136A (en) Fungicidal compositions containing 6-floroindole
ZA772612B (en) Pharmaceutical compositions
AU2574877A (en) Pharmaceutical compositions
HK3984A (en) Pharmaceutical compositions
ZA771408B (en) Pharmaceutical compositions
IL57881A (en) Pharmaceutical compositions containing benzamidoalkyl merccaptans
JPS52122633A (en) Pharmaceutical composition
NZ185320A (en) Pesticidal compositions containing 2-halo-5-nitrothiazoles